Literature DB >> 11021871

Recent advances: rheumatology.

R Madhok1, H Kerr, H A Capell.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11021871      PMCID： PMC1118683          DOI： 10.1136/bmj.321.7265.882

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  34 in total

1.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

2.  Nutrition: risk factors for osteoarthritis.

Authors:  T McAlindon; D T Felson
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

3.  Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors:  R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

4.  Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

Authors:  E Tsakonas; A A Fitzgerald; M A Fitzcharles; A Cividino; J C Thorne; A M'Seffar; L Joseph; C Bombardier; J M Esdaile
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial.

Authors:  S C O'Reilly; K R Muir; M Doherty
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

6.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Authors:  C J Hawkey; J A Karrasch; L Szczepañski; D G Walker; A Barkun; A J Swannell; N D Yeomans
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

7.  Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

Authors:  C Egsmose; B Lund; G Borg; H Pettersson; E Berg; U Brodin; L Trang
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

8.  Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime.

Authors:  M V Hurley; D L Scott
Journal:  Br J Rheumatol       Date:  1998-11

9.  Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis.

Authors:  S ten Wolde; F C Breedveld; J Hermans; J P Vandenbroucke; M A van de Laar; H M Markusse; M Janssen; H R van den Brink; B A Dijkmans
Journal:  Lancet       Date:  1996-02-10       Impact factor: 79.321

10.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321
View more
  4 in total

1.  Development and psychometric validation of a new patient satisfaction instrument: the osteoARthritis Treatment Satisfaction (ARTS) questionnaire.

Authors:  J Pouchot; E Trudeau; S C Hellot; G Meric; A Waeckel; J Goguel
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

2.  Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.

Authors:  Gajendra Kumar; Amita Srivastava; Surinder Kumar Sharma; T Divakara Rao; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

Review 3.  Patient preference in the management of postmenopausal osteoporosis with bisphosphonates.

Authors:  Jean-Yves Reginster; Véronique Rabenda
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

4.  Magnet therapy for the relief of pain and inflammation in rheumatoid arthritis (CAMBRA): a randomised placebo-controlled crossover trial.

Authors:  Stewart J Richmond
Journal:  Trials       Date:  2008-09-12       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.